UPC Analytics
ENDE
Overview · Filed:

ACT_547520/2023

InfringementMain Infringement ActionMunich LDInfringement Action
Coverage: Partial.Reasoning extracted with partial coverage — some sections may be incomplete.
Plain-English summary

DexCom Inc. brought an infringement action against multiple Abbott entities before the Munich Local Division concerning EP 3 350 592 (a CGM system patent). Abbott counterclaimed for revocation and succeeded: the court found the patent invalid for lack of novelty/inventive step both as granted and in DexCom's two auxiliary request forms, and revoked it entirely. DexCom's failure to advance specific arguments distinguishing the dependent claims was noted as a further reason those claims fell. All infringement claims were dismissed and DexCom was ordered to bear all costs.

Accepted arguments
What the court agreed with — by party.
  • Patent EP 3 350 592 invalid as granted and in all auxiliary request forms

    RespondentLegal basis: Art. 138(1) EPC; Art. 65(2) UPCA

    Note: Munich LD upheld Abbott's counterclaim for revocation, finding the CGM patent invalid for lack of novelty/inventive step in all claim versions.

  • Dependent claims are invalid for same reasons as claim 1 where claimant provides no specific arguments distinguishing dependent claims

    RespondentLegal basis: Art. 138(1) EPC

    Note: Claimant merely asserted dependent claims contain claim 1 features and are novel/inventive for the same reasons; no specific arguments advanced; court held dependent claims also invalid.

Rejected arguments
What the court did not agree with — and why.
  • EP 3 350 592 as granted is valid

    ClaimantLegal basis: Art. 54/56 EPC

    Reason: Patent found invalid for lack of novelty/inventive step as granted.

  • Auxiliary requests 1 and 2 are valid

    ClaimantLegal basis: Art. 54/56 EPC

    Reason: Both auxiliary requests also found invalid; dismissed.